These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 6169605)
1. In vitro and in vivo effects of ditazol on human platelets malonylaldehyde (MDA) production. Fabris F; Casonato A; Randi M; Girolami A Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(3):433-8. PubMed ID: 6169605 [TBL] [Abstract][Full Text] [Related]
2. The effect of certain antiplatelet drugs on in vitro malonylaldehyde (MDA) production. Fabris F; Casonato A; De Marco L; Girolami A Arzneimittelforschung; 1979; 29(7):981-3. PubMed ID: 583000 [TBL] [Abstract][Full Text] [Related]
3. [Effect of factor VIII concentrate on malondialdehyde release by normal human platelets]. Geroldi D; Cervini L Boll Soc Ital Biol Sper; 1979 Apr; 55(7):675-81. PubMed ID: 121702 [TBL] [Abstract][Full Text] [Related]
4. Thrombin-induced platelet malondialdehyde (MDA) formation in normal subjects and in women taking oral contraceptives. Hellstern P; Miyashita C; Köhler M; Wenzel E; Holl W Thromb Haemost; 1982 Dec; 48(3):325-6. PubMed ID: 7164021 [TBL] [Abstract][Full Text] [Related]
5. Malondialdehyde formation in rat platelet-rich plasma. II. Modification of the reaction kinetics by aspirin and indomethacin in vitro. Livio M; Rajtar G; Merino J; de Gaetano G Thromb Haemost; 1980 Oct; 44(2):52-5. PubMed ID: 7455991 [TBL] [Abstract][Full Text] [Related]
6. [Effect of captopril on superoxide dismutase (SOD-1) activity and malondialdehyde (MDA) level in blood platelets in patients with arterial hypertension]. Tkaczewski W; Kedziora J; Buczyński A; Dziekański S; Ryniec A Kardiol Pol; 1989; 32(3):138-41. PubMed ID: 2695684 [TBL] [Abstract][Full Text] [Related]
7. [The effect of heparin on the formation of platelet malondialdehyde]. Charvát J; Rysánek K; Spánková H Cas Lek Cesk; 1985 Mar; 124(12):357-9. PubMed ID: 4005906 [No Abstract] [Full Text] [Related]
8. Increased erythrocyte membrane arachidonate and platelet malondialdehyde (MDA) production in psoriasis: normalization after fish-oil. Schena D; Chieregato GC; de Gironcoli M; Girelli D; Olivieri O; Stanzial AM; Corrocher R; Bassi A; Ferrari S; Perazzoli P Acta Derm Venereol Suppl (Stockh); 1989; 146():42-4. PubMed ID: 2609880 [TBL] [Abstract][Full Text] [Related]
9. Malondialdehyde formation in rat platelet-rich plasma. I.A kinetic approach. Rajtar G; Livio M; Merino J; de Gaetano G Thromb Haemost; 1980 Oct; 44(2):49-51. PubMed ID: 7455990 [TBL] [Abstract][Full Text] [Related]
10. Influence of thiofedrine on platelet aggregation, intraplatelet cyclic cAMP and malondialdehyde in rats. Qu YZ; Li XX Methods Find Exp Clin Pharmacol; 1994 May; 16(4):253-6. PubMed ID: 8051984 [TBL] [Abstract][Full Text] [Related]
11. Side effects of sodium valproate (sodium di-N-propylacetate) on malonyldialdehyde-production and other platelet function tests. von Voss H; Schulte-Berbühl R; Göbel U Minerva Pediatr; 1978 Sep; 30(17):1397-404. PubMed ID: 375054 [No Abstract] [Full Text] [Related]
12. [Changes in platelet production of malondialdehyde in diabetics treated with dilazep]. Carleo R; Buda GR; Cerciello A; Dell'Aversano R; Monaco GP; Trovato C; Vigilante M Boll Soc Ital Biol Sper; 1983 Dec; 59(12):1838-41. PubMed ID: 6671043 [TBL] [Abstract][Full Text] [Related]
13. [An ex-vivo technic for the pharmacologic evaluation of potential antiphlogistics by ex-vivo determination of the rate of malondialdehyde (MDA) formation using rat platelets]. Schmollack W; Scholz U; Bekemeier H Pharmazie; 1986 Jun; 41(6):395-7. PubMed ID: 3763681 [TBL] [Abstract][Full Text] [Related]
14. Pressure-induced metabolic activation of platelets demonstrated in vitro by determination of malondialdehyde formation. Torsellini A; Doni L; Palinski W; Guidi G; Lombardi V Thromb Haemost; 1984 Aug; 52(1):4-6. PubMed ID: 6238444 [TBL] [Abstract][Full Text] [Related]
15. [Determination of malondialdehyde (MDA) formation in thrombocytes]. Stepanauskas M; Norden C; Heine H; Staak R Z Med Lab Diagn; 1982; 23(6):332-8. PubMed ID: 7170826 [No Abstract] [Full Text] [Related]
16. [MDA formation by platelets and plasmatic BTG levels in patients suffering from acute myocardial infarction (author's transl)]. Davì G; Traina M; Novo S; Pinto A; Piraino GL; Marano G; Alfano R G Ital Cardiol; 1981; 11(9):1238-41. PubMed ID: 6173283 [TBL] [Abstract][Full Text] [Related]
17. Platelet malondialdehyde in cardiovascular disease: effect of prosthetic heart valves and cardioactive drugs on production. Sullivan JM; Taylor JC; Samaha JK Thromb Haemost; 1980 Oct; 44(2):76-80. PubMed ID: 7455995 [TBL] [Abstract][Full Text] [Related]
18. Comparison of the malondialdehyde formation in megakaryocytes and platelets after in vivo and in vitro administration of aspirin. Saigo K; Ryo R; Nakaya Y; Yamaguchi N Nihon Ketsueki Gakkai Zasshi; 1987 Feb; 50(1):138-47. PubMed ID: 3109189 [No Abstract] [Full Text] [Related]
19. The recovery of platelet malondialdehyde production after a single intake of aspirin--the effect of dosage. Takayama H; Okuma M; Uchino H Thromb Haemost; 1982 Aug; 48(1):13-7. PubMed ID: 6813990 [TBL] [Abstract][Full Text] [Related]
20. [Assessment of platelet aggregation and malondialdehyde production in patients with chronic cor pulmonale]. Zhou YC; Weng XZ; Qiu HG Zhonghua Nei Ke Za Zhi; 1987 Nov; 26(11):638-40, 677. PubMed ID: 3443028 [No Abstract] [Full Text] [Related] [Next] [New Search]